Edward P. Jordan

SVP, Sales and Marketing at AMAG PHARMACEUTICALS, INC. · on record since Feb 25, 2014
Chief Commercial Officer at HUMANIGEN, INC · on record since Sep 22, 2020

Insider trading activity of Edward P. Jordan

Transactions on record: 17; since Feb 25, 2014

Open-market buys: 1; $29K

Open-market sells: 1; $295.2K

Companies traded: 2; last filing Jul 29, 2022

Figures computed from official regulatory filings — .

Companies where Edward P. Jordan has traded

HUMANIGEN, INC10 tx · $488.5K · Jul 29, 2022
AMAG PHARMACEUTICALS, INC.7 tx · $64K · Mar 5, 2015

Track record of Edward P. Jordan

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Edward P. Jordan

Co-insiders of Edward P. Jordan

5AM CO INVESTORS LLCHUMANIGEN, INC
5AM Partners LLCHUMANIGEN, INC
5AM VENTURES LLCHUMANIGEN, INC
Adage Capital Advisors, L.L.C.AMAG PHARMACEUTICALS, INC.
ADAGE CAPITAL PARTNERS GP LLCAMAG PHARMACEUTICALS, INC.
ADAGE CAPITAL PARTNERS LPAMAG PHARMACEUTICALS, INC.
ALLEN LEE F MD PhDAMAG PHARMACEUTICALS, INC.
Alloy Annex I, LLCHUMANIGEN, INC
Alloy Annex I, L.P.HUMANIGEN, INC
Alloy Corporate 2000, L.P.HUMANIGEN, INC
Alloy Investors 2000, L.P.HUMANIGEN, INC
Alloy Partners 2000, L.P.HUMANIGEN, INC
Alloy Ventures 2000, LLCHUMANIGEN, INC
Alloy Ventures 2000, L.P.HUMANIGEN, INC
Anthion Partners II LLCHUMANIGEN, INC
Apps Charles DavidAMAG PHARMACEUTICALS, INC.
Arkowitz DavidAMAG PHARMACEUTICALS, INC.
ARMISTICE CAPITAL, LLCAMAG PHARMACEUTICALS, INC.
Armistice Capital Master Fund Ltd.AMAG PHARMACEUTICALS, INC.
Atchinson RobertAMAG PHARMACEUTICALS, INC.
AVALLONE MICHAEL NAMAG PHARMACEUTICALS, INC.
Azan AlainHUMANIGEN, INC
BAFFI ROBERTHUMANIGEN, INC
BARLIANT RONALDHUMANIGEN, INC
BAXTER INTERNATIONAL INCHUMANIGEN, INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
HUMANIGEN, INCListing unverified	Jul 29, 2022	AwardD (derivative)	455,010	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Mar 4, 2022	Buy	12,500	2.32 USD	$29K	conv 80ClusterFirst in 12mo	SEC
HUMANIGEN, INCListing unverified	Jan 14, 2022	AwardD (derivative)	43,763	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Jan 4, 2022	AwardD (derivative)	29,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Nov 26, 2021	OtherD (derivative)	-4,966	4.53 USD	$22.5K		SEC
HUMANIGEN, INCListing unverified	Oct 4, 2021	AwardD (derivative)	4,966	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Jun 9, 2021	Sell	-14,700	20.08 USD	$295.2K		SEC
HUMANIGEN, INCListing unverified	Jun 9, 2021	ExerciseD (derivative)	-14,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Jun 9, 2021	Exercise	14,700	9.65 USD	$141.9K		SEC
HUMANIGEN, INCListing unverified	Sep 22, 2020	AwardD (derivative)	88,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 5, 2015	Other	-1,287	49.70 USD	$64K		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	15,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 25, 2014	AwardD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 25, 2014	Award	15,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
HUMANIGEN, INCListing unverified	Jul 29, 2022	AwardD (derivative)	455,010	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Mar 4, 2022	Buy	12,500	2.32 USD	$29K	conv 80ClusterFirst in 12mo	SEC
HUMANIGEN, INCListing unverified	Jan 14, 2022	AwardD (derivative)	43,763	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Jan 4, 2022	AwardD (derivative)	29,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Nov 26, 2021	OtherD (derivative)	-4,966	4.53 USD	$22.5K		SEC
HUMANIGEN, INCListing unverified	Oct 4, 2021	AwardD (derivative)	4,966	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Jun 9, 2021	Sell	-14,700	20.08 USD	$295.2K		SEC
HUMANIGEN, INCListing unverified	Jun 9, 2021	ExerciseD (derivative)	-14,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Jun 9, 2021	Exercise	14,700	9.65 USD	$141.9K		SEC
HUMANIGEN, INCListing unverified	Sep 22, 2020	AwardD (derivative)	88,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 5, 2015	Other	-1,287	49.70 USD	$64K		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	15,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 25, 2014	AwardD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 25, 2014	Award	15,000	—	n/a (No price was disclosed in the filing)		SEC